Plasma-derived medicinal products self-sufficiency from national plasma: to what extent?

Abstract

Achievement of self-sufficiency in blood and plasma products from voluntary non remunerated healthy donors has been advocated by WHO in a resolution dating back nearly 40 years1,2 and it is the current basis for the collection of blood in almost all European countries; in Italy, self-sufficiency obtained through donations from volunteer donors, not only in labile components but also in plasma products, is an aim stated by the legislation3. Is self-sufficiency from national plasma a practice goal for Italy and, if so, to what extent is it feasible? In this paper we will try to analyse some factors that can contribute to answer the question: the origin of plasma for fractionation and the rate of collection, the influence of production processes, the products for which self-sufficiency would be advisable and the policies for an appropriate utilisation of plasma products.

Cite this work

No public copy is stored for this record, so only the metadata is cited.

Stored only when both papers are in the corpus — 12 citations exist upstream.

Papers that cite the same references — the relational fallback while embeddings are still backfilling.